Across TCGA pan-cancer cohorts, CFAP44 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated CFAP44 data layer compared with 7 for mutation status.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher CFAP44 RNA is associated with better overall survival. In most high-consensus cancer types, elevated CFAP44 expression acts as an unfavorable survival marker, although some lineages such as BLCA and HNSC show a favorable association.
BLCA, KICH, and HNSC are the cancer types where CFAP44 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.